Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular testing for microsatellite instability and its value in tumor characterization.

Matthias Kloor1, Magnus von Knebel Doeberitz, Johannes F Gebert

  • 1Institute of Molecular Pathology, Im Neuenheimer Feld 220/221, 69120 Heidelberg, Germany. matthias.kloor@med.uni-heidelberg.de

Expert Review of Molecular Diagnostics
|July 15, 2005
PubMed
Summary

Microsatellite instability testing is crucial for identifying hereditary colorectal cancer and may impact prognosis and treatment. Understanding this molecular marker can lead to tailored therapies for microsatellite-unstable tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence Rates of Melanoma and Lung Cancer Are Generally Low in the Lynch Syndromes and Vary Across <i>path_MMR</i> Variants: A Prospective Lynch Syndrome Database Report.

Cancers·2026
Same author

A Micro-costing Study of Community-Based Primary HPV Self-Sampling and Triage Test for Cervical Cancer Screening in Rural Cambodia.

PharmacoEconomics - open·2026
Same author

KRAS and BRAF mutations modify adjuvant chemotherapy outcomes in early stage colorectal cancer.

NPJ precision oncology·2026
Same author

Effect of a polygenic risk score in patients with late-onset, early-onset, familial, or hereditary colorectal cancer.

JNCI cancer spectrum·2026
Same author

Immune Cell Score as a Predictor of Adjuvant Chemotherapy Effectiveness in Stage II Colorectal Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Detection of MSI signals from peripheral blood for monitoring response to immune checkpoint blockade therapy in patients with advanced microsatellite-unstable gastrointestinal cancers: A pilot study.

International journal of cancer·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Molecular analysis of tumors uses high-throughput technologies for genetic and expression profiling.
  • Despite advancements, molecular approaches are rarely used in routine clinical diagnosis and therapy.
  • Microsatellite instability (MSI) testing is a validated tool for hereditary nonpolyposis colorectal cancer (HNPCC).

Purpose of the Study:

  • To review the current significance of MSI testing in various tumor types.
  • To explore the diagnostic and therapeutic implications of MSI.
  • To provide insights into future developments in MSI analysis.

Main Methods:

  • Review of current literature on microsatellite instability testing.
  • Analysis of MSI's role in hereditary cancer syndromes, particularly colorectal cancer.

Related Experiment Videos

  • Examination of MSI's impact on patient prognosis and treatment decisions.

    • Main Results:

    • MSI testing is established for identifying hereditary nonpolyposis colorectal cancer.
    • Emerging evidence suggests MSI analysis is vital for prognosis and therapeutic decisions in colorectal cancer.
    • Understanding the MSI phenotype can guide novel diagnostic and therapeutic strategies.

    Conclusions:

    • Microsatellite instability testing holds significant current value in oncology.
    • Further understanding of MSI is essential for developing targeted treatments for microsatellite-unstable tumors.
    • MSI analysis is poised for increased clinical importance in cancer management.